Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 23, 2007, Pages 6411-6416

  Shah, Bhahwal A ^a   Kumar, Ajay ^a   Gupta, Pankaj ^a   Sharma, Madhunika ^a   Sethi, Vijay K ^a   Saxena, Ajit K ^a   Singh, Jaswant ^a   Qazi, Ghulam N ^a   Taneja, Subhash C ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Boswellic acid; 11 Keto boswellic acid; Amino analogues; Cytotoxicity; DNA fragmentation; Epimers

Indexed keywords

11 KETO BETA BOSWELLIC ACID; 3 ALPHA HYDROXY 4 BETA AMINO 24 NORURS 12 ENE DERIVATIVE; BETA BOSWELLIC ACID; BOSWELLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BOSWELLIA; CELL LINE, TUMOR; DNA FRAGMENTATION; GROWTH INHIBITORS; HUMANS; TRITERPENES;

EID: 35648956678     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.10.011     Document Type: Article

References (46)

1. Kirtikar K.R., and Basu B.D. Indian Medicinal Plants I. 2nd ed. (1935), M/s Periodical Experts, Delhi, India p 521
2. Chatterjee G.K., and Pal S.D. Indian Drugs 21 (1984) 431
3. Ammon H.P., Safayhi H., Mack T., and Sabieraj J. J. Ethnopharmacol. 38 (1993) 113
4. Mahajan B., Sethi V.K., Taneja S.C., and Dhar K.L. Phytochemistry 39 (1995) 453
5. Safayhi H., Mack T., Sabieraj J., Anazodo M.I., Subramanian L.R., and Ammon H.P. J. Pharmacol. Exp. Ther. 261 (1992) 1143
6. Schweizer S., von Brocke A.F., Boden S.E., Bayer E., Ammon H.P., and Safayhi H. J. Nat. Prod. 63 (2000) 1058
7. Safayhi H., Sailer E.R., and Ammon H.P. Mol. Pharmacol. 47 (1995) 1212
8. Sharma M.L., Bani S., and Singh G.B. Int. J. Immunopharmacol. 11 (1989) 647
9. Singh S., Khajuria A., Taneja S.C., Khajuria R.K., Singh J., and Qazi G.N. Bioorg. Med. Chem. Lett. 17 (2007) 3706
10. Gupta I., Parihar A., Malhotra P., Singh G.B., Ludtke R., Safayhi H., and Ammon H.P. Eur. J. Med. Res. 2 (1997) 37
11. Gupta I., Parihar A., Malhotra P., Gupta S., Ludtke R., Safayhi H., and Ammon H.P. Planta Med. 67 (2001) 391
12. Gupta A., Gupta V., Parihar A., Gupta S., Ludtke R., Safayhi H., and Ammon H.P. Eur. J. Med. Res. 3 (1998) 511
13. Kapil A., and Moza N. Int. J. Immunopharmacol. 14 (1992) 1139
14. Safayhi H., Mack T., and Ammon H.P. Biochem. Pharmacol. 41 (1991) 1536
15. Han R. Stem Cells 12 (1994) 53
16. Shashi B., Kumar A., Malik F., Andotra S.S., Sethi V.K., Kaur I., Taneja S.C., Qazi G.N., and Singh J. Apoptosis (2007) 10.1007/s10495-007-0105-5
17. Glaser T., Winter S., Groscurth P., Safayhi H., Sailer E.R., and Ammon H.P. Br. J. Cancer 80 (1999) 756
18. Jannsen G., Bode U., Breu H., Dohm B., Engelbrecht V., and Gobel U. Klin. Padiatr. 212 (2000) 189
19. Winkling M., Sarikaya S., Rahmanian A., Jodicke A., and Boker D.K. J. Neurooncol. 46 (2000) 97
20. Hoernlein R.F., Orlikowsky T., Zehrer C., Niethammer D., Sailer E.R., Simmet T., Dannecker G.E., and Ammon H.P. J. Pharmacol. Exp. Ther. 288 (1999) 613
21. Jing Y., Nakajo S., Xia L., Nakaya K., Fang Q., Waxman S., and Han R. Leuk. Res. 23 (1999) 43
22. Shao Y., Ho C.T., Chin C.K., Badmaev V., Ma W., and Huang M.T. Planta Med. 64 (1998) 328
23. Syrovets T., Buchele B., Gedig E., Slupsky J.R., and Simmet T. Mol. Pharmacol. 63 (2000) 1058
24. Liu J.J., Nilsson A., Oredsson S., Badmaev V., Zhao W.Z., and Duan R.D. Carcinogenesis 23 (2002) 2087
25. Bergmeier S.C. Tetrahedron 56 (2000) 2561
26. Coppola G.M., and Schuster H.F. Asymmetric Synthesis: Construction of Chiral Molecules Using Amino Acids (1987), Wiley, New York
27. Gupta P., Shah B.A., Parshad R., Qazi G.N., and Taneja S.C. Green Chem. (2007) 10.1039/b701192j
28. Ms Merrell Pharmaceuticals, WO-9602499, 1996
29. Ms DuPont Pharmaceuticals Co., WO-0174784, 2001
30. Ms Aventis Pharmaceuticals, WO-0119833, 2001
31. Ms Sankyo Co., EP-0543662, 1996.
32. Umezawa H., Aoyagi T., Suda H., Hamada M., and Takeuchi T. J. Antibiot. 29 (1976) 97
33. Nakamura H., Suda H., Takita T., Auyagi T., Umezawa H., and Iitaka Y.Y. J. Antibiot. 29 (1976) 102
34. Ino K., Goto S., Nomura S., Isobe K.I., Nawa A., Okamoto T., and Tomoda Y. Anticancer Res. 15 (1995) 2081
35. Stratmann K., Burgoyne D.L., Moore R.E., Patterson G.M.L., and Smith C.D. J. Org. Chem. 59 (1994) 7219
36. Schaefer J.P., and Wheatley P.J. J. Org. Chem. 33 (1968) 166
37. Schaefer J.P., and Wheatley P.J. J. Chem. Soc., Chem. Commun. (1967) 578
38. Grollman A.P., and Walsh M.J. Biol. Chem. 242 (1967) 3226
39. He A.-W.R., and Cory J.G. Anticancer Res. 19 (1999) 421
40. Diacel Chemical Industries Ltd. European Patent Application No. 0654 534 A2, November 18, 1994.
41. Wang Z.M., Zhang X.L., and Sharpless K.B. Tetrahedron Lett. 34 (1993) 2267
42. Ager D.J., Prakash I., and Schaad D.R. Chem. Rev. 96 (1996) 835
43. Martha S.R., Omar M.M., Cecilia A.P., Leticia Q., and Eusebio J. J. Org. Chem. 68 (2003) 2369
44. +.
45. Beton J.L., Halsall T.G., and Jones E.R.H. J. Chem. Soc. (1956) 2904
46. Monks A., Scudiero D., Skehan P., Shoemaker R., Paul K., Vistica D., Hose C., Langley J., Cronise P., Wolff A.V., Goodrich M.G., Campbell H., Mayo J., and Boyd M. J. Natl. Cancer Inst. 83 (1991) 757